Trials / Terminated
TerminatedNCT03295552
Decitabine Plus Carboplatin in the Treatment of Metastatic TNBC
Decitabine Plus Carboplatin in the Treatment of Metastatic Triple Negative Breast Cancer
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effect of novel DNA demethylating agents in the treatment of metastatic TNBC
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Decitabine | decitabine 7mg/m2, d1-d5, q3w |
| DRUG | Carboplatin | carboplatin AUC = 6, d6, q3w |
Timeline
- Start date
- 2017-11-15
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2017-09-28
- Last updated
- 2022-04-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03295552. Inclusion in this directory is not an endorsement.